Quaker Houghton Announces Executive Appointments: Christine Johnson Named Chief Transformation Officer, Dr. André Frodl Promoted to VP of R&D
Reuters
Oct 02, 2025
<a href="https://laohu8.com/S/KWR">Quaker Houghton</a> Announces Executive Appointments: Christine Johnson Named Chief Transformation Officer, Dr. André Frodl Promoted to <a href="https://laohu8.com/S/VP..UK">VP</a> of R&D
Quaker Houghton announced two executive leadership changes. Christine Johnson has been appointed Senior Vice President and Chief Transformation Officer, joining from McKinsey & Company. Dr. André Frodl has been promoted to Vice President, R&D - Metals and Metalworking, following the retirement of Dr. Dave Slinkman.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quaker Chemical Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: PH88210) on October 01, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.